Regulation FD Disclosure

Business Context and Reporting Period

This Form 8-K is a current report filed by Healthcare Trust, Inc. (not National Healthcare Properties, Inc.) on August 30, 2023. The filing serves to disclose an investor presentation and a conference call transcript regarding the Company's financial and operating results for the quarter ended June 30, 2023.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Investor Presentation (Exhibit 99.1) and Conference Call Transcript (Exhibit 99.2), which are referenced but not detailed in the body of this report.

Material Changes

No material changes to financial results or operations are described in the text of this filing. The document solely announces the availability of materials discussing the Q2 2023 results.

Guidance, Outlook, and Risks

The filing includes a standard forward-looking statements disclaimer. Management highlights the following risks and uncertainties that could cause actual results to differ materially from expectations:

  • Adverse effects of the global COVID-19 pandemic.
  • Geopolitical instability due to the conflict between Russia and Ukraine, including sanctions and impacts on the global economy.
  • Inflationary conditions and higher interest rate environments.
  • Risks detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.

The Company explicitly states it undertakes no obligation to update forward-looking statements unless required by law.

Investor Verification Checklist

  • Verify the specific Q2 2023 financial metrics (revenue, FFO, debt levels) in the attached Exhibit 99.1 (Investor Presentation).
  • Review the Exhibit 99.2 (Transcript) for management's commentary on the higher interest rate environment and its impact on the portfolio.
  • Confirm the status of the Company's preferred stock classes (7.375% Series A and 7.125% Series B) listed on the Nasdaq Global Market.
  • Note that the presentation and transcript are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.